Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$49.27 - $66.08 $541 - $726
-11 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$43.77 - $63.22 $1.45 Million - $2.1 Million
-33,191 Reduced 99.97%
11 $1,000
Q4 2021

Feb 11, 2022

SELL
$49.55 - $74.59 $19.7 Million - $29.7 Million
-397,817 Reduced 92.3%
33,202 $1.76 Million
Q3 2021

Nov 12, 2021

BUY
$57.6 - $70.59 $5.3 Million - $6.49 Million
91,964 Added 27.12%
431,019 $30.4 Million
Q2 2021

Aug 13, 2021

BUY
$51.81 - $118.56 $17.6 Million - $40.2 Million
339,055 New
339,055 $22.6 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.